Nephrotoxicity of antiretroviral therapy in an HIV-infected patient

被引:10
|
作者
Said, S. M.
Nasr, S. H.
Samsa, R.
Markowitz, G. S.
D'Agati, V. D.
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[2] S Mt Nephrol, Belleville, NJ USA
关键词
D O I
10.1038/sj.ki.5002134
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A 31-year-old human immunodeficiency virus (HIV)-positive Hispanic male presented with gross hematuria and renal insufficiency. The patient had an episode of gross hematuria 3 months before that lasted 1 week and subsided spontaneously. Urologic workup including abdominal and pelvic computed tomography (CT) scan, cystoscopy, and renal ultrasound was negative. Gross hematuria recurred a few weeks later. During this 3-month time period, the patient's serum creatinine increased from 1.6mg/dl (141 mu mol/l) to 2.7mg/dl (239 mu mol/l). Past medical history was significant for HIV infection for 7 years, acquired via homosexual contact, and bipolar disorder. At the time of presentation, the patient was on multiple antiretroviral medications including indinavir (800mg twice a day), ritonavir (100mg twice a day), and lamivudine (150mg a day), all of which had been initiated 26 months before. The patient was also being treated for bipolar disorder with olanzapine (10mg a day) and lamotrigine (100mg a day). Other medications included AndroGel (R) (testosterone replacement gel) (once a day) and dronabinol (2.5mg a day). On physical examination, the patient had a blood pressure of 120/80mm Hg, a heart rate of 62/min, and a weight of 155 pounds. He was afebrile. Cardiovascular, pulmonary, and abdominal examinations were unremarkable. He had a rash on his hands and lower abdomen. The rash was pruritic with excoriations, presumably allergic, and subsequently resolved. There was no evidence of edema. Laboratory examination showed a total leukocyte count of 8000/mm(3) (normal range 3800-10 800/mm(3)) with an absolute lymphocyte count of 2688/mm(3) (normal range 850-3900/mm(3)), eosinophil count 128/mm(3) (normal range 15-550/mm(3)), hematocrit 39% (normal range 38.5-50.0%), platelet count 634 x 10(9)/l (normal range 140-400 x 10(9)/l), 24 h urine protein 1.3 g, serum albumin 4.5 g/dl (45g/l) (normal range 3.7-5.1 g/dl (37-51 g/l)), and creatinine clearance 27cm(3)/min. The following serologies were negative: antinuclear antibody, anti-double-stranded DNA antibody, anti- neutrophil cytoplasmic antibody, anti-GBM antibody, hepatitis B surface antigen, and hepatitis C antibody. His viral load was < 50 HIV-1 RNA copies/ml (reference range < 50 copies/ ml). The CD4 count was 515/mm(3) (reference range 490-1740/mm(3)). Urinalysis showed trace protein, moderate blood, pH 6.0, negative nitrite, and positive leukocytes. Microscopic evaluation of the urine sediment (performed once) revealed 10 red blood cells/high power field, no casts, and no crystals. The clinical differential diagnosis included HIV-associated nephropathy (HIVAN), immune complex glomerulonephritis, and highly active antiretroviral therapy (HAART)-associated nephrotoxicity. A renal biopsy was performed.
引用
收藏
页码:1071 / 1075
页数:5
相关论文
共 50 条
  • [41] Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy
    Rodriguez, Monica
    Flores, Paul
    Ahumada, Victor
    Vazquez-Vazquez, Lorena
    Alvarado-de la Barrera, Claudia
    Reyes-Teran, Gustavo
    CASE REPORTS IN MEDICINE, 2012, 2012
  • [42] Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient
    Deeks, SG
    Martin, JN
    AIDS, 2001, 15 (01) : 117 - 119
  • [43] Resolution of recalcitrant hand warts in an HIV-infected patient treated with potent antiretroviral therapy
    Spach, DH
    Colven, R
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (05) : 818 - 821
  • [44] Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy
    Brendel, K
    Legrand, M
    Taburet, AM
    Baron, G
    Goujard, C
    Mentré, F
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (03) : 373 - 383
  • [45] Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen
    Turner, BJ
    Zhang, DZ
    Laine, C
    Pomerantz, RJ
    Cosler, L
    Hauck, WW
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (01) : 20 - 29
  • [46] Factors related to and consequences of adherence to antiretroviral therapy in an ambulatory HIV-infected patient cohort
    Deloria-Knoll, M
    Chmiel, JS
    Moorman, AC
    Wood, KC
    Holmberg, SD
    Palella, FJ
    AIDS PATIENT CARE AND STDS, 2004, 18 (12) : 721 - 727
  • [47] Nitric oxide levels in HIV-infected, untreated patients and HIV-infected patients receiving antiretroviral therapy
    Soccal, Renata Mezomo
    Mainardi de Carvalho, Jose Antonio
    Bochi, Guilherme Vargas
    Moresco, Rafael Noal
    Paz da Silva, Jose Edson
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 302 - 307
  • [48] Adherence to antiretroviral therapy in HIV-infected patients in Sousse, Tunisia
    Hachfi, W.
    Bellazreg, F.
    Bougmiza, I
    Gloulou, O.
    Kaabia, N.
    Bahri, F.
    MEDECINE ET SANTE TROPICALES, 2012, 22 (01): : 105 - 107
  • [49] The effectiveness of highly active antiretroviral therapy in HIV-infected patients
    Jensen-Fangel, S
    DANISH MEDICAL BULLETIN, 2004, 51 (04) : 371 - 392
  • [50] ANTIRETROVIRAL THERAPY IN HIV-INFECTED ADULTS - WHICH REGIMENS ARE RECOMMENDED
    LANCASTER, DJ
    LANCASTER, LL
    POSTGRADUATE MEDICINE, 1994, 95 (01) : 47 - &